Sutro Biopharma Company

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.


Connections from

Estimated Revenue: $10M to $50M
Funding Status: IPO
Headquarters: South San Francisco, California, United States
Total Funding: $347 000 000
Last Funding Date: 2020-12-14
Founded Date: 2003
Technology: Biologics
Industry: Women Cancer Treatment
Last Funding Type: Post-IPO Equity
Employee Number: 51-100